risankizumab

Atlanta, Georgia, United States, November 9, 2026 UCB, a global biopharmaceutical company, has announced additional Week 24 findings from...

North Chicago, Illinois, United States, Aug. 27, 2026 AbbVie has submitted a regulatory application to the European Medicines Agency...